FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

Prestige Consumer Healthcare Inc. PBH

Weak   broader-coverage candidate · Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal ca

On FrontierLab's discovery record since 2026-08-11 (10 days ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-08-12), not the curated Frontier signal.

Key quality signals

Revenue growth (YoY)-1.4%
Gross margin53.3%
Gross profits / assets0.13
Rule of 4024.9
Net margin26.3%
Cash runway (months)
PEG
Price / sales2.3

Quality checklist

Fundamentals — snapshot as of 2026-08-12

StageEstablished
Share issuance (YoY)-4.5% · buying back shares
Moat
TAM
P/E (trailing)15
EPS (trailing)$3.57
Burn multiple
Gross-margin trend (pts)-2.9
Cash / assets0.02
Net debt / EBITDA6.3
Statements as ofQ1 FY2027 · filed 2026-08-06

Momentum context — a snapshot from 2026-08-12, not current

Price at surface$53.60 (as of 2026-08-12)
52-week range$42.62 – $71.07
% off 52-wk high-24.6%
RSI (14)60
Relative volume0.8×

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-08-12 (end-of-day). How grades are computed →